Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. [electronic resource]
Producer: 20201120Description: 337-345 p. digitalISSN:- 1720-8386
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Kidney Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab -- adverse effects
- Retrospective Studies
- Skin Neoplasms -- drug therapy
- Thyroid Diseases -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.